Drug Discovery & Development

Strategies & Technologies Driving Drug Discovery to Market

Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Grants Orphan Drug Designation for EUR-1073

March 10, 2009 5:47 am | News | Comments

Eurand N.V. announced that the FDA has granted orphan drug designation for EUR-1073 (beclomethasone diproprionate) in pediatric patients.

TOPICS:

INTERPHEX 2009

March 10, 2009 5:39 am | News | Comments

The INTERPHEX Conference will feature three days of comprehensive educational opportunities to reflect the trends and challenges facing pharmaceutical and biopharmaceutical professionals today.

TOPICS:

Interchangeable Reactor Tray

March 10, 2009 5:34 am | Product Releases | Comments

A new interchangeable reactor tray is now available for the Uniqsis FlowSyn Continuous Flow Reactor.

TOPICS:
Advertisement

New Gel Offers Controlled Drug Delivery

March 10, 2009 5:19 am | News | Comments

MIT researchers have demonstrated that a gel composed of small, woven protein fragments can successfully carry and release proteins of different sizes, potentially enabling delivery of drugs such as insulin and trastuzumab (Herceptin).

TOPICS:

Water Purification System

March 10, 2009 5:11 am | Product Releases | Comments

Millipore Corporation introduced the Milli-Q Reference water purification system at Pittcon 2009.

TOPICS:

Synosia Announces Second Agreement with Roche

March 10, 2009 4:26 am | News | Comments

Synosia Therapeutics announced it has entered into a second agreement with Roche, adding a further promising molecule to Synosia’s clinical pipeline.

TOPICS:

PerkinElmer Expands Presence in Asia

March 10, 2009 4:19 am | News | Comments

PerkinElmer, Inc. announced the inauguration of a new Center of Excellence (COE) in Singapore.

TOPICS:

Long-Term Effects of Early Parkinson's Treatments Similar

March 9, 2009 12:37 pm | News | Comments

A study involving two common drugs used to treat early-stage Parkinson's disease shows that, while the drugs each have advantages and disadvantages, the overall impact tends to even out over a long period of treatment.

TOPICS:
Advertisement

Seahorse Bioscience Acquires BioProcessors Corp.

March 9, 2009 12:13 pm | News | Comments

Seahorse Bioscience announced the acquisition of BioProcessors Corp.

TOPICS:

Evotec and Roche to Develop EVT 101

March 9, 2009 11:50 am | News | Comments

Evotec AG and Roche announced that they have entered into an agreement for Phase 2 clinical development of EVT 101 in patients with treatment-resistant depression.

TOPICS:

Linear Motion Products

March 9, 2009 10:43 am | Product Releases | Comments

HaydonKerk Motion Solutions showcased its MotoDrive PDE linear actuator and MotoRGS motorized linear slide assembly in Booth # 2473 at Pittcon 2009.

TOPICS:

Novozymes Biopharma Signs License Agreement with GE Healthcare

March 9, 2009 10:32 am | News | Comments

Novozymes Biopharma announced a signed license agreement with GE Healthcare Life Sciences.

TOPICS:

Tecan and GE Healthcare Collaborate

March 9, 2009 10:03 am | News | Comments

Tecan and GE Healthcare are working together to bring increased quality and efficiency to process development.

TOPICS:

Spray Drying System

March 9, 2009 9:54 am | Product Releases | Comments

Sono-Tek Corporation announces that it will showcase the SonoDry 1000 spray drying system in booth 983 at INTERPHEX 2009.

TOPICS:

UHPLC Product

March 9, 2009 9:35 am | Product Releases | Comments

ESA Biosciences, Inc. launched an ultra-high-performance version of its Corona CAD at Pittcon 2009.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading